PHATHOM PHARMACEUTICALS, INC. (PHAT) Free cash flow 2019–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$167.0MFY2025 · since FY2019: -$36.6M → -$167.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$167.0M | +37.4% |
| FY2024 | -$266.9M | -91.7% |
| FY2023 | -$139.2M | +5.7% |
| FY2022 | -$147.6M | +0.8% |
| FY2021 | -$148.8M | -110.4% |
| FY2020 | -$70.7M | -93.0% |
| FY2019 | -$36.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice